DEF 14AThe Ballot
Avalo Therapeutics, Inc. files DEF 14A
Filed Apr 25, 2022 · 4y ago · Accession 0001628280-22-010113
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Avalo Therapeutics, Inc.
- Ticker
- AVTX
- CIK
- 1534120
- Form type
- DEF 14A
- Filing date
- Apr 25, 2022
- Report date
- Jun 14, 2022
- Document
- def14a-2022.htm
- Size
- 1.5 MB